Literature DB >> 19690187

Birth characteristics and risk of prostate cancer: the contribution of genetic factors.

Sven Cnattingius1, Frida Lundberg, Sven Sandin, Henrik Grönberg, Anastasia Iliadou.   

Abstract

BACKGROUND: Prostate cancer has a strong hereditary component, but it has been proposed that hormonal influences in utero may contribute to offspring risk. We investigated the associations between birth characteristics and the risk of prostate cancer in twins, and whether possible associations could be confounded by familial factors, such as shared environment and common genes.
METHODS: All like-sexed male twins in the Swedish Twin Registry, born from 1926 to 1958 and alive in 1973, were eligible. Data were obtained from birth records, and 11,420 male twins with reliable birth weight data were included in the final study population. Hazard ratios with 95% confidence intervals (CI) from Cox regression models were used to estimate associations between birth characteristics and risk of prostate cancer. Paired analysis was done to account for potential confounding by familial factors.
RESULTS: Compared with twins with a birth weight of 2,500 to 2,999 g, the hazard ratio (95% CI) for twins with a higher birth weight (>or=3,000 g) corresponded to 1.22 (0.94-1.57). In analyses within twin pairs, in which both twins had a birth weight of >or=2,500 g, a 500 g increase in birth weight was associated with an increased risk of prostate cancer within dizygotic twin pairs (odds ratio, 1.41; 95% CI, 1.02-1.57), but not within monozygotic twin pairs (odds ratio, 1.06; 95% CI, 0.61-1.84).
CONCLUSIONS: High birth weight is associated with an increased risk of prostate cancer. The difference in risk within dizygotic and monozygotic twin pairs may be due to genetic factors playing an important role in this association.

Entities:  

Mesh:

Year:  2009        PMID: 19690187     DOI: 10.1158/1055-9965.EPI-09-0366

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  10 in total

1.  Analysis of baseline parameters in the HALT polycystic kidney disease trials.

Authors:  Vicente E Torres; Arlene B Chapman; Ronald D Perrone; K Ty Bae; Kaleab Z Abebe; James E Bost; Dana C Miskulin; Theodore I Steinman; William E Braun; Franz T Winklhofer; Marie C Hogan; Frederic R Oskoui; Cass Kelleher; Amirali Masoumi; James Glockner; Neil J Halin; Diego R Martin; Erick Remer; Nayana Patel; Ivan Pedrosa; Louis H Wetzel; Paul A Thompson; J Philip Miller; Catherine M Meyers; Robert W Schrier
Journal:  Kidney Int       Date:  2011-12-28       Impact factor: 10.612

Review 2.  The maternal womb: a novel target for cancer prevention in the era of the obesity pandemic?

Authors:  Frank A Simmen; Rosalia C M Simmen
Journal:  Eur J Cancer Prev       Date:  2011-11       Impact factor: 2.497

3.  Neonatal exposure to estradiol/bisphenol A alters promoter methylation and expression of Nsbp1 and Hpcal1 genes and transcriptional programs of Dnmt3a/b and Mbd2/4 in the rat prostate gland throughout life.

Authors:  Wan-yee Tang; Lisa M Morey; Yuk Yin Cheung; Lynn Birch; Gail S Prins; Shuk-mei Ho
Journal:  Endocrinology       Date:  2011-11-22       Impact factor: 4.736

4.  Height at diagnosis and birth-weight as risk factors for osteosarcoma.

Authors:  Lisa Mirabello; Ruth Pfeiffer; Gwen Murphy; Najat C Daw; Ana Patiño-Garcia; Rebecca J Troisi; Robert N Hoover; Chester Douglass; Joachim Schüz; Alan W Craft; Sharon A Savage
Journal:  Cancer Causes Control       Date:  2011-04-05       Impact factor: 2.506

5.  Epigenetics meets endocrinology.

Authors:  Xiang Zhang; Shuk-Mei Ho
Journal:  J Mol Endocrinol       Date:  2011-02       Impact factor: 5.098

6.  Racial variation in umbilical cord blood leptin concentration in male babies.

Authors:  Gabriel Y Lai; Sabine Rohrmann; Tanya Agurs-Collins; Catherine G Sutcliffe; Gary Bradwin; Nader Rifai; Jessica L Bienstock; Elizabeth A Platz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-02-09       Impact factor: 4.254

7.  Childhood height and birth weight in relation to future prostate cancer risk: a cohort study based on the copenhagen school health records register.

Authors:  Michael B Cook; Michael Gamborg; Julie Aarestrup; Thorkild I A Sørensen; Jennifer L Baker
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-10-02       Impact factor: 4.254

8.  The emergence of human-evolutionary medical genomics.

Authors:  Bernard J Crespi
Journal:  Evol Appl       Date:  2010-10-12       Impact factor: 5.183

9.  Influence of In Utero Maternal and Neonate Factors on Cord Blood Leukocyte Telomere Length: Clues to the Racial Disparity in Prostate Cancer?

Authors:  Kari A Weber; Christopher M Heaphy; Sabine Rohrmann; Beverly Gonzalez; Jessica L Bienstock; Tanya Agurs-Collins; Elizabeth A Platz; Alan K Meeker
Journal:  Prostate Cancer       Date:  2016-12-14

10.  Clinical presentation of prostate cancer in black South Africans.

Authors:  Elizabeth A Tindall; L Richard Monare; Desiree C Petersen; Smit van Zyl; Rae-Anne Hardie; Alpheus M Segone; Philip A Venter; M S Riana Bornman; Vanessa M Hayes
Journal:  Prostate       Date:  2014-04-09       Impact factor: 4.104

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.